140 related articles for article (PubMed ID: 28881733)
1. Positive regulation of TAZ expression by EBV-LMP1 contributes to cell proliferation and epithelial-mesenchymal transition in nasopharyngeal carcinoma.
He J; Tang F; Liu L; Chen L; Li J; Ou D; Zhang L; Li Z; Feng D; Li W; Sun LQ
Oncotarget; 2017 Aug; 8(32):52333-52344. PubMed ID: 28881733
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus LMP1 protein promotes proliferation and inhibits differentiation of epithelial cells via activation of YAP and TAZ.
Singh DR; Nelson SE; Pawelski AS; Kansra AS; Fogarty SA; Bristol JA; Ohashi M; Johannsen EC; Kenney SC
Proc Natl Acad Sci U S A; 2023 May; 120(20):e2219755120. PubMed ID: 37155846
[TBL] [Abstract][Full Text] [Related]
3. Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma.
Horikawa T; Yang J; Kondo S; Yoshizaki T; Joab I; Furukawa M; Pagano JS
Cancer Res; 2007 Mar; 67(5):1970-8. PubMed ID: 17332324
[TBL] [Abstract][Full Text] [Related]
4. LMP1 promotes expression of insulin-like growth factor 1 (IGF1) to selectively activate IGF1 receptor and drive cell proliferation.
Tworkoski K; Raab-Traub N
J Virol; 2015 Mar; 89(5):2590-602. PubMed ID: 25520502
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma.
Yoshizaki T; Kondo S; Wakisaka N; Murono S; Endo K; Sugimoto H; Nakanishi S; Tsuji A; Ito M
Cancer Lett; 2013 Aug; 337(1):1-7. PubMed ID: 23689138
[TBL] [Abstract][Full Text] [Related]
6. Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells.
Murono S; Inoue H; Tanabe T; Joab I; Yoshizaki T; Furukawa M; Pagano JS
Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6905-10. PubMed ID: 11381123
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic alterations induced by the Hong Kong-prevalent Epstein-Barr virus-encoded LMP1 variant (2117-LMP1) in nasopharyngeal epithelial cells.
Lo AK; Huang DP; Lo KW; Chui YL; Li HM; Pang JC; Tsao SW
Int J Cancer; 2004 May; 109(6):919-25. PubMed ID: 15027126
[TBL] [Abstract][Full Text] [Related]
8. Role of the Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma.
Morris MA; Dawson CW; Young LS
Future Oncol; 2009 Aug; 5(6):811-25. PubMed ID: 19663731
[TBL] [Abstract][Full Text] [Related]
9. Targeting Exosomal EBV-LMP1 Transfer and miR-203 Expression via the NF-κB Pathway: The Therapeutic Role of Aspirin in NPC.
Zuo L; Xie Y; Tang J; Xin S; Liu L; Zhang S; Yan Q; Zhu F; Lu J
Mol Ther Nucleic Acids; 2019 Sep; 17():175-184. PubMed ID: 31265948
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus latent membrane protein 1 induces the chemotherapeutic target, thymidine phosphorylase, via NF-kappaB and p38 MAPK pathways.
Chen CC; Chen LC; Liang Y; Tsang NM; Chang YS
Cell Signal; 2010 Jul; 22(7):1132-42. PubMed ID: 20214978
[TBL] [Abstract][Full Text] [Related]
11. Regulation of survivin and CDK4 by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cell lines.
Ai MD; Li LL; Zhao XR; Wu Y; Gong JP; Cao Y
Cell Res; 2005 Oct; 15(10):777-84. PubMed ID: 16246267
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway.
Stewart S; Dawson CW; Takada K; Curnow J; Moody CA; Sixbey JW; Young LS
Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15730-5. PubMed ID: 15498875
[TBL] [Abstract][Full Text] [Related]
13. LMP1 promotes nasopharyngeal carcinoma metastasis through NTRK2-mediated anoikis resistance.
Li Z; Zhou Z; Wu X; Zhou Q; Liao C; Liu Y; Li D; Shen L; Feng D; Yang L
Am J Cancer Res; 2020; 10(7):2083-2099. PubMed ID: 32775002
[TBL] [Abstract][Full Text] [Related]
14. DNAzymes targeted to EBV-encoded latent membrane protein-1 induce apoptosis and enhance radiosensitivity in nasopharyngeal carcinoma.
Lu ZX; Ma XQ; Yang LF; Wang ZL; Zeng L; Li ZJ; Li XN; Tang M; Yi W; Gong JP; Sun LQ; Cao Y
Cancer Lett; 2008 Jul; 265(2):226-38. PubMed ID: 18353539
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha.
Wakisaka N; Kondo S; Yoshizaki T; Murono S; Furukawa M; Pagano JS
Mol Cell Biol; 2004 Jun; 24(12):5223-34. PubMed ID: 15169887
[TBL] [Abstract][Full Text] [Related]
16. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma.
Zheng H; Li LL; Hu DS; Deng XY; Cao Y
Cell Mol Immunol; 2007 Jun; 4(3):185-96. PubMed ID: 17601372
[TBL] [Abstract][Full Text] [Related]
17. Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes.
Thornburg NJ; Raab-Traub N
J Virol; 2007 Dec; 81(23):12954-61. PubMed ID: 17881446
[TBL] [Abstract][Full Text] [Related]
18. Identification of functional differences between prototype Epstein-Barr virus-encoded LMP1 and a nasopharyngeal carcinoma-derived LMP1 in human epithelial cells.
Dawson CW; Eliopoulos AG; Blake SM; Barker R; Young LS
Virology; 2000 Jun; 272(1):204-17. PubMed ID: 10873763
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 3 (TLR3) functions as a pivotal target in latent membrane protein 1 (LMP1)-mediated nasopharyngeal carcinoma cell proliferation.
Zhou L; Hang X; Xie L
Int J Clin Exp Pathol; 2020; 13(2):153-162. PubMed ID: 32211095
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
